Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.

Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, Lerman MI, Zabarovsky ER.

Cancer Res. 2004 Sep 15;64(18):6438-43.

2.

[Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].

Anedchenko EA, Dmitriev AA, Krasnov GS, Kondrat'eva TT, Kopantsev EP, Vinogradova TV, Zinov'eva MV, Zborovskaia IB, PolotskiÄ­ BE, Sakharova OV, Kashuba VI, ZabarovskiÄ­ ER, Senchenko VN.

Mol Biol (Mosk). 2008 Nov-Dec;42(6):965-76. Russian.

PMID:
19140316
4.

An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.

Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, Lerman MI, Klein G, Zabarovsky ER.

Cancer Res. 2003 Jan 15;63(2):404-12.

5.

Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.

Senchenko VN, Anedchenko EA, Kondratieva TT, Krasnov GS, Dmitriev AA, Zabarovska VI, Pavlova TV, Kashuba VI, Lerman MI, Zabarovsky ER.

BMC Cancer. 2010 Mar 1;10:75. doi: 10.1186/1471-2407-10-75.

6.

Loss of expression of the DRR 1 gene at chromosomal segment 3p21.1 in renal cell carcinoma.

Wang L, Darling J, Zhang JS, Liu W, Qian J, Bostwick D, Hartmann L, Jenkins R, Bardenhauer W, Schutte J, Opalka B, Smith DI.

Genes Chromosomes Cancer. 2000 Jan;27(1):1-10.

PMID:
10564580
7.

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP.

Nat Genet. 2000 Jul;25(3):315-9.

PMID:
10888881
8.

RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.

Oh JJ, Taschereau EO, Koegel AK, Ginther CL, Rotow JK, Isfahani KZ, Slamon DJ.

Lung Cancer. 2010 Dec;70(3):253-62. doi: 10.1016/j.lungcan.2010.02.012. Epub 2010 Mar 24.

PMID:
20338664
9.

NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway.

Jayachandran G, Ueda K, Wang B, Roth JA, Ji L.

PLoS One. 2010 Aug 5;5(8):e11994. doi: 10.1371/journal.pone.0011994.

10.

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

Agathanggelou A, Honorio S, Macartney DP, Martinez A, Dallol A, Rader J, Fullwood P, Chauhan A, Walker R, Shaw JA, Hosoe S, Lerman MI, Minna JD, Maher ER, Latif F.

Oncogene. 2001 Mar 22;20(12):1509-18.

11.

Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.

Angeloni D, ter Elst A, Wei MH, van der Veen AY, Braga EA, Klimov EA, Timmer T, Korobeinikova L, Lerman MI, Buys CH.

Genes Chromosomes Cancer. 2006 Jul;45(7):676-91.

PMID:
16607615
12.

Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.

Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, Ermilova V, Kazubskaya T, Garkavtseva R, Zabarovska VI, Kashuba VI, Kisselev LL, Minna JD, Lerman MI, Klein G, Braga EA, Zabarovsky ER.

Oncogene. 2004 Jul 29;23(34):5719-28.

PMID:
15208675
13.

The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21.

Latif F, Duh FM, Bader S, Sekido Y, Li H, Geil L, Zbar B, Minna JD, Lerman MI.

Hum Genet. 1997 Mar;99(3):334-41.

PMID:
9050919
14.

A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3.

Oh JJ, West AR, Fishbein MC, Slamon DJ.

Cancer Res. 2002 Jun 1;62(11):3207-13.

15.

Promoter methylation study of the H37/RBM5 tumor suppressor gene from the 3p21.3 human lung cancer tumor suppressor locus.

Oh JJ, Boctor BN, Jimenez CA, Lopez R, Koegel AK, Taschereau EO, Phan DT, Jacobsen SE, Slamon DJ.

Hum Genet. 2008 Feb;123(1):55-64. Epub 2007 Nov 22.

PMID:
18038152
16.

3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.

Oh JJ, Razfar A, Delgado I, Reed RA, Malkina A, Boctor B, Slamon DJ.

Cancer Res. 2006 Apr 1;66(7):3419-27.

17.

Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.

Liu Q, Zhao XY, Bai RZ, Liang SF, Nie CL, Yuan Z, Wang CT, Wu Y, Chen LJ, Wei YQ.

Oncol Rep. 2009 Nov;22(5):1069-75.

PMID:
19787223
18.

A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.

Timmer T, Terpstra P, van den Berg A, Veldhuis PM, Ter Elst A, Voutsinas G, Hulsbeek MM, Draaijers TG, Looman MW, Kok K, Naylor SL, Buys CH.

Eur J Hum Genet. 1999 May-Jun;7(4):478-86.

19.

The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.

Sekine I, Sato M, Sunaga N, Toyooka S, Peyton M, Parsons R, Wang W, Gazdar AF, Minna JD.

Oncogene. 2005 Apr 14;24(16):2735-8.

PMID:
15735765
20.

The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells.

Ueda K, Kawashima H, Ohtani S, Deng WG, Ravoori M, Bankson J, Gao B, Girard L, Minna JD, Roth JA, Kundra V, Ji L.

Cancer Res. 2006 Oct 1;66(19):9682-90.

Supplemental Content

Support Center